| SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS |
The
total fair value of Broker Units was $45,361, estimated using the Black-Scholes option pricing model with the following weighted average
assumptions:
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS
| | |
CAD$ | | |
$ | |
| Share price at grant date | |
$ | 3.04 | | |
$ | 2.21 | |
| Risk-free interest rate | |
| 2.59 | % | |
| 2.59 | % |
| Expected life | |
| 3 years | | |
| 3 years | |
| Expected volatility | |
| 118.4 | % | |
| 118.4 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Grant date fair value per warrant | |
$ | 1.85 | | |
$ | 1.34 | |
The
total fair value of these Warrants was $2,774,214 and the Broker Units was $644,058, estimated using the Black-Scholes option pricing
model with the following weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Share price at grant date | |
$ | 4.88 | | |
$ | 3.46 | |
| Risk-free interest rate | |
| 2.39 | % | |
| 2.39 | % |
| Expected life | |
| 3 years | | |
| 3 years | |
| Expected volatility | |
| 118.4 | % | |
| 118.4 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Grant date fair value per warrant | |
$ | 3.29 | | |
$ | 2.33 | |
The
total fair value of these Compensation Warrants was $660,900, estimated using the Black-Scholes option pricing model with the following
weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Share price at grant date | |
$ | 11.46 | | |
$ | 8.38 | |
| Risk-free interest rate | |
| 2.72 | % | |
| 2.72 | % |
| Expected life | |
| 3 years | | |
| 3 years | |
| Expected volatility | |
| 120.6 | % | |
| 120.6 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Grant date fair value per warrant | |
$ | 8.20 | | |
$ | 5.99 | |
The
total fair value of these Compensation Warrants was $495,635, estimated using the Black-Scholes option pricing model with the following
weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Share price at grant date | |
$ | 13.20 | | |
$ | 9.52 | |
| Risk-free interest rate | |
| 2.61 | % | |
| 2.61 | % |
| Expected life | |
| 3 years | | |
| 3 years | |
| Expected volatility | |
| 123.9 | % | |
| 123.9 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Grant date fair value per warrant | |
$ | 9.78 | | |
$ | 7.05 | |
|
The total fair value of the compensation
warrants was $920,786, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
SCHEDULE
OF WEIGHTED AVERAGE ASSUMPTIONS
| | |
CAD$ | | |
$ | |
| Share price at grant date | |
$ | 46.17 | | |
$ | 32.20 | |
| Risk-free interest rate | |
| 2.88 | % | |
| 2.88 | % |
| Expected life | |
| 3
years | | |
| 3
years | |
| Expected volatility | |
| 121.6 | % | |
| 121.6 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Grant date fair value per warrant | |
$ | 33.31 | | |
$ | 23.23 | |
The total fair value of the broker warrants
was $165,518, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Weighted average share price at grant date | |
$ | 12.35 | | |
$ | 8.87 | |
| Weighted average risk-free interest rate | |
| 3.01 | % | |
| 3.01 | % |
| Expected life | |
| 3
years | | |
| 3
years | |
| Expected volatility | |
| 100 | % | |
| 100 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Weighted average grant date fair value per warrant | |
$ | 7.32 | | |
$ | 5.25 | |
The total fair value of the broker
warrants was $58,290, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Weighted average share price at grant date | |
$ | 13.23 | | |
$ | 9.49 | |
| Weighted average risk-free interest rate | |
| 3.05 | % | |
| 3.05 | % |
| Expected life | |
| 3
years | | |
| 3
years | |
| Expected volatility | |
| 100 | % | |
| 100 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Weighted average grant date fair value per warrant | |
$ | 8.01 | | |
$ | 5.74 | |
The total fair value of the broker warrants
was $134,813, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Weighted average share price at grant date | |
$ | 19.71 | | |
$ | 14.53 | |
| Weighted average risk-free interest rate | |
| 2.90 | % | |
| 2.90 | % |
| Expected life | |
| 3
years | | |
| 3
years | |
| Expected volatility | |
| 100 | % | |
| 100 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Weighted average grant date fair value per warrant | |
$ | 11.54 | | |
$ | 8.51 | |
The total fair value of the broker warrants
was $181,394, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
| | |
CAD$ | | |
$ | |
| Weighted average share price at grant date | |
$ | 27.54 | | |
$ | 19.97 | |
| Weighted average risk-free interest rate | |
| 4.25 | % | |
| 4.25 | % |
| Expected life | |
| 2
years | | |
| 2
years | |
| Expected volatility | |
| 100 | % | |
| 100 | % |
| Expected dividends | |
| Nil | | |
| Nil | |
| Weighted average grant date fair value per warrant | |
$ | 14.12 | | |
$ | 10.32 | |
|
| SCHEDULE OF WARRANTS OUTSTANDING |
Warrants
outstanding as at December 31, 2025 are summarized below:
SCHEDULE OF WARRANTS OUTSTANDING
| | |
Number of warrants | | |
Weighted Average
Exercise Price (CAD$) | | |
Exercise Price (USD$ equivalent) (1) | |
| Balance, March 31, 2024 | |
| 878,061 | | |
$ | 41.10 | | |
$ | 29.99 | |
| Issued | |
| 1,340,158 | | |
| 40.16 | | |
| 29.30 | |
| Exercised | |
| (122,993 | ) | |
| 24.09 | | |
| 17.58 | |
| Expired | |
| (2 | ) | |
| 21.60 | | |
| 15.76 | |
| Balance, March 31, 2025 | |
| 2,095,224 | | |
$ | 41.50 | | |
$ | 30.28 | |
| Issued | |
| 3,023,944 | | |
| 8.84 | | |
| 6.45 | |
| Expired | |
| (368,303 | ) | |
| 26.54 | | |
| 19.36 | |
| Balance, December 31, 2025 | |
| 4,750,865 | | |
$ | 21.87 | | |
$ | 15.96 | |
| (1) | Converted
at balance sheet rate. |
|
Warrants outstanding as at March 31, 2025 are summarized below:
SCHEDULE
OF WARRANTS OUTSTANDING
| | |
Number of warrants | | |
Weighted Average Exercise Price (CAD$) | | |
Exercise Price (USD$
equivalent) (1) | |
| Balance, March 31, 2023 | |
| 969,941 | | |
$ | 26.73 | | |
$ | 18.59 | |
| Issued | |
| 338,319 | | |
| 75.03 | | |
| 52.19 | |
| Exercised | |
| (430,199 | ) | |
| 35.38 | | |
| 24.61 | |
| Balance, March 31, 2024 | |
| 878,061 | | |
$ | 41.10 | | |
$ | 28.59 | |
| Issued | |
| 1,340,158 | | |
| 40.16 | | |
| 27.93 | |
| Exercised | |
| (122,993 | ) | |
| 24.09 | | |
| 16.76 | |
| Expired | |
| (2 | ) | |
| 21.60 | | |
| 15.02 | |
| Balance, March 31, 2025 | |
| 2,095,224 | | |
$ | 41.50 | | |
$ | 28.86 | |
| (1) | Converted
at balance sheet rate. |
|
| SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE |
As
of December 31, 2025, the Company’s outstanding share purchase warrants expire as follows:
SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE
| Expiry date | |
Weighted Average Remaining Contractual Life in Years | | |
Exercise Price (CAD$) | | |
Exercise Price (USD$ equivalent) (1) | | |
Outstanding | |
| April 15, 2026 | |
| 0.29 | | |
| 10.80 | | |
| 7.88 | | |
| 46,296 | |
| April 17, 2026 | |
| 0.29 | | |
| 27.00 | | |
| 19.70 | | |
| 3,348 | |
| April 29, 2026 | |
| 0.33 | | |
| 27.00 | | |
| 19.70 | | |
| 6,618 | |
| May 16, 2026 | |
| 0.37 | | |
| 27.00 | | |
| 19.70 | | |
| 1,702 | |
| July 6, 2026 | |
| 0.51 | | |
| 55.35 | | |
| 40.38 | | |
| 29,227 | |
| July 6, 2026 | |
| 0.51 | | |
| 68.85 | | |
| 50.23 | | |
| 294,694 | |
| August 15, 2026 | |
| 0.62 | | |
| 27.00 | | |
| 19.70 | | |
| 45,496 | |
| August 17, 2026 | |
| 0.63 | | |
| 40.50 | | |
| 29.55 | | |
| 126,853 | |
| August 30, 2026 | |
| 0.66 | | |
| 40.50 | | |
| 29.55 | | |
| 43,062 | |
| September 17, 2026 | |
| 0.71 | | |
| 40.50 | | |
| 29.55 | | |
| 12,494 | |
| December 22, 2026 | |
| 0.98 | | |
| 32.40 | | |
| 23.64 | | |
| 809 | |
| January 8, 2027 | |
| 1.02 | | |
| 40.50 | | |
| 29.55 | | |
| 28 | |
| June 20, 2027 | |
| 1.47 | | |
| 40.50 | | |
| 29.55 | | |
| 255,185 | |
| September 26, 2027 | |
| 1.74 | | |
| 21.60 | | |
| 15.76 | | |
| 10,562 | |
| September 26, 2027 | |
| 1.74 | | |
| 32.40 | | |
| 23.64 | | |
| 114,354 | |
| November 8, 2027 | |
| 1.85 | | |
| 13.50 | | |
| 9.85 | | |
| 14,444 | |
| November 8, 2027 | |
| 1.85 | | |
| 18.90 | | |
| 13.79 | | |
| 85,699 | |
| November 15, 2027 | |
| 1.87 | | |
| 13.50 | | |
| 9.85 | | |
| 2,229 | |
| November 15, 2027 | |
| 1.87 | | |
| 18.90 | | |
| 13.79 | | |
| 15,290 | |
| December 9, 2027 | |
| 1.94 | | |
| 13.50 | | |
| 9.85 | | |
| 3,707 | |
| December 9, 2027 | |
| 1.94 | | |
| 18.90 | | |
| 13.79 | | |
| 28,519 | |
| January 9, 2028 | |
| 2.02 | | |
| 52.92 | | |
| 38.61 | | |
| 235,906 | |
| January 9, 2028 | |
| 2.02 | | |
| 42.39 | | |
| 30.93 | | |
| 26,420 | |
| February 25, 2028 | |
| 2.15 | | |
| 52.92 | | |
| 38.61 | | |
| 257,312 | |
| March 9, 2028 | |
| 2.19 | | |
| 18.90 | | |
| 13.79 | | |
| 66,667 | |
| April 28, 2028 | |
| 2.33 | | |
| 15.00 | | |
| 10.94 | | |
| 458,333 | |
| April 28, 2028 | |
| 2.33 | | |
| 12.00 | | |
| 8.76 | | |
| 70,334 | |
| July 11, 2028 | |
| 2.53 | | |
| 11.50 | | |
| 8.39 | | |
| 614,153 | |
| November 6, 2028 | |
| 2.85 | | |
| 6.00 | | |
| 4.38 | | |
| 186,667 | |
| November 6, 2028 | |
| 2.85 | | |
| 7.00 | | |
| 5.11 | | |
| 1,236,667 | |
| December 18, 2028 | |
| 2.97 | | |
| 3.04 | | |
| 2.22 | | |
| 23,026 | |
| December 18, 2028 | |
| 2.97 | | |
| 7.00 | | |
| 5.11 | | |
| 434,764 | |
| | |
| 2.24 | | |
$ | 21.87 | | |
$ | 15.96 | | |
| 4,750,865 | |
Notes:
| (1) | Converted
at balance sheet rate. |
| (2) | Warrants
expiring July 6, 2026 |
Pre-Consolidation
Exercise Terms: 1 Warrant + CAD$2.55 ($1.86 at balance sheet rate) = 1 Class A Subordinate Voting share.
Post-Consolidation
Exercise Terms: 27 Warrants + CAD$68.85 ($50.23 at balance sheet rate) = 1 New Class A Subordinate Voting share.
For
presentation purposes, the Company divided the total outstanding warrants by 27 to reflect 1 warrant + CAD$68.85 ($50.23 at balance sheet
rate) = 1 New Class A Subordinate Voting share.
|
As
of March 31, 2025, the Company’s outstanding share purchase warrants expire as follows:
SCHEDULE
OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE
| Expiry date | |
Weighted Average Remaining Contractual Life in Years | | |
Exercise Price (CAD$) | | |
Exercise Price (USD$
equivalent) (1) | | |
Outstanding | |
| April 3, 2025 | |
| 0.01 | | |
| 32.40 | | |
| 22.54 | | |
| 117 | |
| April 20, 2025 | |
| 0.05 | | |
| 32.40 | | |
| 22.54 | | |
| 194 | |
| June 2, 2025 | |
| 0.17 | | |
| 32.40 | | |
| 22.54 | | |
| 1,149 | |
| June 16, 2025 | |
| 0.21 | | |
| 32.40 | | |
| 22.54 | | |
| 1,017 | |
| July 10, 2025 | |
| 0.28 | | |
| 32.40 | | |
| 22.54 | | |
| 98 | |
| August 15, 2025 | |
| 0.38 | | |
| 32.40 | | |
| 22.54 | | |
| 8,279 | |
| August 15, 2025 | |
| 0.38 | | |
| 21.60 | | |
| 15.02 | | |
| 42,663 | |
| August 15, 2025 (2) | |
| 0.38 | | |
| 27.00 | | |
| 18.78 | | |
| 360,098 | |
| August 25, 2025 | |
| 0.40 | | |
| 32.40 | | |
| 22.54 | | |
| 184 | |
| April 15, 2026 | |
| 1.04 | | |
| 10.80 | | |
| 7.51 | | |
| 46,296 | |
| April 17, 2026 | |
| 1.05 | | |
| 27.00 | | |
| 18.78 | | |
| 3,348 | |
| April 29, 2026 | |
| 1.08 | | |
| 27.00 | | |
| 18.78 | | |
| 6,618 | |
| May 16, 2026 | |
| 1.13 | | |
| 27.00 | | |
| 18.78 | | |
| 1,702 | |
| July 6, 2026 | |
| 1.27 | | |
| 55.35 | | |
| 38.50 | | |
| 29,227 | |
| July 6, 2026 (3) | |
| 1.27 | | |
| 68.85 | | |
| 47.89 | | |
| 294,694 | |
| August 17, 2026 | |
| 1.38 | | |
| 40.50 | | |
| 28.17 | | |
| 126,853 | |
| August 30, 2026 | |
| 1.42 | | |
| 40.50 | | |
| 28.17 | | |
| 43,062 | |
| September 17, 2026 | |
| 1.47 | | |
| 40.50 | | |
| 28.17 | | |
| 12,494 | |
| December 22, 2026 | |
| 1.73 | | |
| 32.40 | | |
| 22.54 | | |
| 809 | |
| January 8, 2027 | |
| 1.78 | | |
| 40.50 | | |
| 28.17 | | |
| 28 | |
| June 20, 2027 | |
| 2.22 | | |
| 40.50 | | |
| 28.17 | | |
| 255,185 | |
| September 26, 2027 | |
| 2.49 | | |
| 21.60 | | |
| 15.02 | | |
| 10,562 | |
| September 26, 2027 | |
| 2.49 | | |
| 32.40 | | |
| 22.54 | | |
| 114,354 | |
| November 8, 2027 | |
| 2.61 | | |
| 13.50 | | |
| 9.39 | | |
| 14,444 | |
| November 8, 2027 | |
| 2.61 | | |
| 18.90 | | |
| 13.15 | | |
| 85,699 | |
| November 15, 2027 | |
| 2.63 | | |
| 13.50 | | |
| 9.39 | | |
| 2,229 | |
| November 15, 2027 | |
| 2.63 | | |
| 18.90 | | |
| 13.15 | | |
| 15,290 | |
| December 9, 2027 | |
| 2.69 | | |
| 13.50 | | |
| 9.39 | | |
| 3,707 | |
| December 9, 2027 | |
| 2.69 | | |
| 18.90 | | |
| 13.15 | | |
| 28,519 | |
| January 9, 2028 | |
| 2.78 | | |
| 52.92 | | |
| 36.81 | | |
| 235,906 | |
| January 9, 2028 | |
| 2.78 | | |
| 42.39 | | |
| 29.49 | | |
| 26,420 | |
| February 25, 2028 | |
| 2.91 | | |
| 52.92 | | |
| 36.81 | | |
| 257,312 | |
| March 9, 2028 | |
| 2.94 | | |
| 18.90 | | |
| 13.15 | | |
| 66,667 | |
| | |
| 1.83 | | |
$ | 41.50 | | |
| 28.86 | | |
| 2,095,224 | |
Notes:
| (1) | Converted
at balance sheet rate. |
| (2) | Warrants
expiring August 15, 2025: |
Pre-Consolidation exercise terms: 1 warrant
+ CAD$1.00 ($0.6956 at balance sheet rate) = 1 Class A Subordinate Voting share.
Post-Consolidation Exercise Terms: 27 Warrants
+ CAD$27.00 ($18.78 at balance sheet rate) = 1 New Class A Subordinate Voting share.
For presentation purposes, the
Company divided the total outstanding warrants by 27 to reflect 1 warrant + CAD$27.00 ($18.78 at balance sheet rate) = 1 New Class A
Subordinate Voting share.
| (3) | Warrants
expiring July 6, 2026 |
Pre-Consolidation Exercise Terms: 1 Warrant
+ CAD$2.55 ($1.77 at balance sheet rate) = 1 Class A Subordinate Voting share.
Post-Consolidation Exercise Terms: 27 Warrants
+ CAD$68.85 (47.89 at balance sheet rate) = 1 New Class A Subordinate Voting share.
For presentation purposes, the
Company divided the total outstanding warrants by 27 to reflect 1 warrant + CAD$68.85 (47.89 at balance sheet rate) = 1 New Class A
Subordinate Voting share.
VERSES AI INC.
Notes to the Consolidated Financial Statements
For the years ended March 31, 2025 and 2024
(Expressed in United States dollars)
|
|